Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:79-84
Published online before print December 17, 2007, doi: 10.1161/CIRCULATIONAHA.106.671735
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/1/79    most recent
CIRCULATIONAHA.106.671735v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, R. E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cardiomyopathy
*Heart Failure
Related Collections
Right arrow Epidemiology
Right arrow Other heart failure
Right arrow Myocardial cardiomyopathy disease
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Pediatric and congenital heart disease, including cardiovascular surgery
Right arrowRelated Article

(Circulation. 2008;117:79-84.)
© 2008 American Heart Association, Inc.


Pediatric Cardiology

New-Onset Heart Failure Due to Heart Muscle Disease in Childhood

A Prospective Study in the United Kingdom and Ireland

Rachel E. Andrews, MRCPCH; Matthew J. Fenton, MRCPCH; Deborah A. Ridout, MSc; Michael Burch, MD, FRCP, FRCPCH, on Behalf of the British Congenital Cardiac Association

From the Department of Congenital Heart Disease, Evelina Children’s Hospital, Guys’ and St Thomas’ NHS Trust (R.E.A.); the Cardiothoracic Unit, Great Ormond Street Hospital for Children NHS Trust (M.J.F., M.B.); and the Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health (D.A.R.); all in London, United Kingdom.

Correspondence to Dr Michael Burch, Cardiothoracic Unit, Great Ormond Street Hospital for Children, Great Ormond St, London WC1N, United Kingdom. E-mail burchm{at}gosh.nhs.uk

Received October 21, 2006; accepted October 19, 2007.

Background— We undertook the first prospective, national, multicenter study to describe the incidence and outcome of heart muscle disease–induced heart failure in children.

Methods and Results— Data were collected on patients admitted to a hospital through 2003 with a first episode of heart failure in the absence of congenital heart disease. All 17 pediatric cardiac centers in the United Kingdom and Ireland participated. Follow-up data were obtained to a minimum of 1 year. The incidence was 0.87/100 000 population <16 years (n=104; 53 girls; 95% confidence interval 0.71 to 1.05 per 100 000). Median age at presentation was 1 year, with 82% in New York Heart Association class III to IV. Causes of heart failure included dilated cardiomyopathy (50 idiopathic, 8 familial), probable myocarditis (23), occult arrhythmia (7), anthracycline toxicity (5), metabolic disease (4), left ventricular noncompaction (3), and other (4). Overall 1-year survival was 82%, and event (death or transplantation)-free survival was 66%. Regression analysis showed older age and reduced systolic function on admission echocardiogram increased the event risk. Only 8% of event-free survivors (n=69) remained in New York Heart Association class III to IV, but 35 required readmission during the study period, and all but 8 remained on medication.

Conclusions— This first national prospective study of new-onset heart failure in children has shown an incidence of 0.87/100 000. Multivariable analysis of survival data indicates a better outcome for younger children and for those with better systolic function at presentation, but overall, one third of children die or require transplantation within 1 year of presentation.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 1-3. [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
D. C. Sane
Letter by Sane Regarding Article, "New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland"
Circulation, June 10, 2008; 117(23): e481 - e481.
[Full Text] [PDF]


Home page
CirculationHome page
S. A. Webber
New-Onset Heart Failure in Children in the Absence of Structural Congenital Heart Disease
Circulation, January 1, 2008; 117(1): 11 - 12.
[Full Text] [PDF]